Font Size: a A A

Effects Of Green Tea Intake To Improve The Quality Of Treatment For Depression In General Practice: A Pilot Randomized Controlled Trial

Posted on:2016-06-09Degree:MasterType:Thesis
Country:ChinaCandidate:H Y HeFull Text:PDF
GTID:2284330503451651Subject:Epidemiology and Health Statistics
Abstract/Summary:PDF Full Text Request
ObjectiveIn our previous study, we have found that green tea intake was associated with a lower prevalence of depressive symptoms in the community-dwelling older population. However, the potential beneficial effects were not evaluated in depression patients. The aim of this study was to determine whether green tea intake had beneficial effects on the quality of treatment for depression. MethodsThirty-three subjects(16 males and 17 females) enrolled into this double-blind, randomized placebo-controlled study of psychiatric outpatients from Dagang hospital received green tea 3g/d(Group 1) or green tea 1.5g/d(Group 2) or placebo(Group 3). The depression and anxiety were evaluated by using the Hamilton Rating Scale for Depression(HAMD), Beck Depression Inventory-II(BDI-II), Patient Health Questionnaire-9(PHQ-9), and Generalized Anxiety Disorder-7(GAD-7). Data through 3 months are reported for all subjects(efficacy, intention-to-treat(ITT) analysis with last-observation-carried-forward for missing data and non-responder imputation for unsatisfactory efficacy discontinuations). ResultsThe dropout rate was 6.0%. In the ITT analyses, when males and females were combined, the means(95% CI) of change in depression and anxiety scales for high-does groups vs low-does vs placebo are: HAMD,-3.50(-8.81, 1.81) vs-5.00(-10.94, 0.94) vs-0.77(-5.43, 3.89)(P = 0.49); BDI,-0.60(-4.72, 3.52) vs-5.25(-9.85,-0.65) vs 1.33(-2.42, 5.09)(P = 0.09); PHQ, 0.50(-2.18, 3.18) vs-3.00(-6.00, 0.00) vs 1.42(-1.03, 3.87)(P = 0.07); GAD, 0.10(-2.56, 2.76) vs-0.63(-3.60, 2.35) vs 0.85(-1.49, 3.18)(P = 0.73), respectively. Similar results also observed in the pre protocol-based analyses. When high-does groups were excluded, the means(95% CI) of change in depression and anxiety scales for low-does vs placebo are: HAMD,-5.00(-10.94, 0.94) vs-0.77(-5.43, 3.89)(P = 0.39); BDI,-5.25(-9.85,-0.65) vs 1.33(-2.42, 5.09)(P = 0.054); PHQ,-3.00(-6.00, 0.00) vs 1.42(-1.03, 3.87)(P = 0.04); GAD,-0.63(-3.60, 2.35) vs 0.85(-1.49, 3.18)(P = 0.47), respectively. ConclusionThese finding suggested that low-does(1.5g/d) green tea intake had a beneficial effect on the quality of treatment for depression outpaients in general practice.
Keywords/Search Tags:Green tea, Depression, double-blind, randomized placebo-controlled trial
PDF Full Text Request
Related items
The effects of isosorbide mononitrate on markers of bone turnover: A double-blind randomized placebo controlled trial
Efficacy Of Chinese Herbal Medicine Xiaojidaozhi Decoction In The Treatment Of Childhood Functional Constipation: A Double Blind,Randomized And Placebo-controlled Trial
Effect Of Citalopram On Depression And Quality Of Life In Patients With Advanced Cancer: A Placebo-controlled Double-blind Randomised Trial
A Multicenter,randomized,double-blind,placebo-controlled Trial And Metabolomics Study On The Intervention Of TCM To Improve IVF Outcome In Advanced-age Patients
Two Doses Of Botulinum Toxin Type A For The Treatment Of Trigeminal Neuralgia:Observation Of Therapeutic Effect From A Randomized, Double-blind,Placebo-controlled Trial
Effect Of Dexamethasone On The Incidence Of Post-dural Puncture Headache After Spinal Anesthesia:a Randomized,Double-blind, Placebo-controlled Trial And A Meta-analysis
Randomized,Double-Blind,Placebo-Controlled Trial For Effects Of TongGuan Capsule On Quality Of Life Of The Patient After PCI
A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury
A randomized, double-blind, placebo-controlled, clinical trial of curcuminoids in oral lichen planus
10 The Safety And Efficacy Of Botulinum Toxin Type A (Heng Li) A Treatment Of Upper Limb Spasticity After Stroke: A Randomized, Double Blind,Placebo,Parallel Controlled Clinical Trial